Across the past 12 months, open-market trades by Artiva Biotherapeutics insiders totaled $109.18 million in purchases (10.07Mn shares) and $2.86 million in sales (363.55K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Capital Management, L.P. Ra | Director, TenPercentOwner | 0 | 17,329,570 | 17,329,570 | 49.0% | 31 Jul, 2026 |
| 2 | Corp. Gc | TenPercentOwner | 4,391,969 | 1,607,734 | 5,999,703 | 17.0% | 28 May, 2026 |
| 3 | Yong-Jun Huh | Director | 0 | 4,567,412 | 4,567,412 | 12.9% | 22 Jul, 2024 |
| 4 | Partners Vi, Llc 5Am | TenPercentOwner | 0 | 2,353,304 | 2,353,304 | 6.7% | 24 Jul, 2024 |
| 5 | Global Strategic Fund Iii, L.P. Venbio | TenPercentOwner | 1,936,637 | 0 | 1,936,637 | 5.5% | 22 Jul, 2024 |
| 6 | Fred Aslan | Chief Executive Officer | 1,457,428 | 0 | 1,457,428 | 4.1% | 03 Nov, 2026 |
| 7 | Jennifer Bush | Coo, Clo, Compliance Officer | 357,720 | 0 | 357,720 | 1.0% | 03 Nov, 2026 |
| 8 | Christopher Horan | Chief Tech Operations Officer | 302,321 | 0 | 302,321 | 0.9% | 03 Nov, 2026 |
| 9 | Thad Allen Huston | Chief Financial Officer | 220,000 | 0 | 220,000 | 0.6% | 10 Mar, 2026 |
| 10 | Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | TenPercentOwner | 194,108 | 0 | 194,108 | 0.5% | 22 Jul, 2024 |
| 11 | Subhashis Banerjee | Chief Medical Officer | 168,738 | 0 | 168,738 | 0.5% | 03 Nov, 2026 |
| 12 | Heather Raymon | Svp, Research And Development | 148,228 | 0 | 148,228 | 0.4% | 19 May, 2026 |
| 13 | Gines Diego Miralles | President Head Of Rd | 122,500 | 0 | 122,500 | 0.3% | 11 Sep, 2026 |
| 14 | Neha Krishnamohan | Chief Financial Officer | 99,356 | 0 | 99,356 | 0.3% | 17 Nov, 2025 |
| 15 | Thorsten Graef | Chief Medical Officer | 80,000 | 0 | 80,000 | 0.2% | 27 Feb, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 02 Nov, 2026 | Fred Aslan | Chief Executive Officer | Disposed S | 62,178 | $4.18 | $259.97K | 1,457,428 | Direct |
| 02 Nov, 2026 | Subhashis Banerjee | Chief Medical Officer | Disposed S | 1,110 | $4.18 | $4.64K | 168,738 | Direct |
| 02 Nov, 2026 | Jennifer Bush | Coo, Clo, Compliance Officer | Disposed S | 8,439 | $4.18 | $35.28K | 357,720 | Direct |
| 02 Nov, 2026 | Christopher Horan | Chief Tech Operations Officer | Disposed S | 10,423 | $4.18 | $43.58K | 302,321 | Direct |
| 06 Oct, 2026 | Fred Aslan | Chief Executive Officer | Disposed S | 23,463 | $7.20 | $168.88K | 1,519,606 | Direct |
| 05 Oct, 2026 | Jennifer Bush | Coo, Clo, Compliance Officer | Disposed S | 8,370 | $6.84 | $57.23K | 366,159 | Direct |
| 05 Oct, 2026 | Subhashis Banerjee | Chief Medical Officer | Disposed S | 1,099 | $6.84 | $7.51K | 169,848 | Direct |
| 05 Oct, 2026 | Fred Aslan | Chief Executive Officer | Disposed S | 61,696 | $6.84 | $421.83K | 1,543,069 | Direct |
| 05 Oct, 2026 | Christopher Horan | Chief Tech Operations Officer | Disposed S | 10,340 | $6.84 | $70.70K | 312,744 | Direct |
| 15 Sep, 2026 | Fred Aslan | Chief Executive Officer | Acquired A | 110,000 | $0.00 | $0 | 1,604,765 | Direct |
| 15 Sep, 2026 | Fred Aslan | Chief Executive Officer | Acquired A | 315,000 | $0.00 | $0 | 315,000 | Direct |
| 10 Sep, 2026 | Capital Management, L.P. Ra | Director, TenPercentOwner | Acquired A | 16,250 | $0.00 | $0 | 16,250 | Indirect |
| 10 Sep, 2026 | Elaine K. Sorg | Director | Acquired A | 16,250 | $0.00 | $0 | 16,250 | Direct |
| 10 Sep, 2026 | Fred Aslan | Chief Executive Officer | Acquired A | 45,000 | $0.00 | $0 | 1,494,765 | Direct |
| 10 Sep, 2026 | Laura Stoppel | Director | Acquired A | 16,250 | $0.00 | $0 | 16,250 | Direct |
| 10 Sep, 2026 | Brian Daniels | Director | Acquired A | 16,250 | $0.00 | $0 | 16,250 | Direct |
| 10 Sep, 2026 | Daniel G. Baker | Director | Acquired A | 16,250 | $0.00 | $0 | 16,250 | Direct |
| 10 Sep, 2026 | Elizabeth L Hougen | Director | Acquired A | 16,250 | $0.00 | $0 | 16,250 | Direct |
| 10 Sep, 2026 | Alison Moore | Director | Acquired A | 16,250 | $0.00 | $0 | 16,250 | Direct |
| 10 Sep, 2026 | Fred Aslan | Chief Executive Officer | Acquired A | 155,000 | $0.00 | $0 | 155,000 | Direct |